Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The corneal endothelial and epithelial ion transport machinery is a complex system of membrane proteins, including the Na+/K+-ATPase pump, carbonic anhydrases (CA-II and CA-IV), and various ion channels (e.g., CFTR, ENaC) and transporters (e.g., SLC4A4, SLC4A11). This machinery is responsible for maintaining the cornea in a state of relative dehydration, known as deturgescence, which is essential for optical transparency (1.1.2, 1.1.4). In the endothelium, the 'pump-leak' mechanism counteracts the natural swelling pressure of the corneal stroma by actively transporting ions into the aqueous humor, followed passively by water (1.2.2). Dysfunction of these transport processes, often due to genetic mutations or aging, leads to corneal edema and vision loss, as seen in Fuchs' endothelial corneal dystrophy (1.2.1). Pharmacological modulation of this machinery is used to treat glaucoma via carbonic anhydrase inhibition and is being explored for treating dry eye disease and corneal endothelial disorders (1.3.1, 1.3.2).
The machinery maintains corneal transparency through the pump-leak mechanism, where active transport of ions (primarily Na+ and HCO3-) by the endothelium and epithelium creates an osmotic gradient that draws water out of the stroma. Drugs like carbonic anhydrase inhibitors reduce this transport to lower intraocular pressure, while experimental agents like CFTR activators or ENaC inhibitors modulate tear volume and composition for dry eye treatment.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Corneal endothelial and epithelial ion transport machinery.